Company Filing History:
Years Active: 2019-2025
Title: Todd Vanderah: Innovator in Pain Treatment
Introduction
Todd Vanderah is a prominent inventor based in Tucson, AZ (US). He has made significant contributions to the field of pain treatment through his innovative research and development of oligopeptides. With a total of 4 patents to his name, Vanderah is recognized for his advancements in medical science.
Latest Patents
One of Vanderah's latest patents focuses on Ang (1-7) derivative oligopeptides for the treatment of pain. This invention provides oligopeptides, particularly Ang-(1-7) derivatives, along with methods for their use and production. In a specific embodiment, these oligopeptides demonstrate higher blood-brain barrier penetration and/or in vivo half-life compared to the native Ang-(1-7). This characteristic allows for a wide range of clinical applications, including the treatment of cognitive dysfunction and pain.
Career Highlights
Vanderah's career is marked by his role at the Arizona Board of Regents on Behalf of the University of Arizona. His work has been instrumental in advancing the understanding and treatment of pain through innovative approaches.
Collaborations
Throughout his career, Vanderah has collaborated with notable colleagues, including Meredith Hay and John Konhilas. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Todd Vanderah's contributions to the field of pain treatment through his innovative oligopeptides highlight his role as a leading inventor. His work continues to pave the way for advancements in medical applications and improved patient outcomes.